Circulating immune complexes in patients with colorectal cancer

Area of Science:

• Immunology
• Oncology
• Biochemistry

Background:

• Host humoral immune response in neoplasia is not fully understood.
• Circulating immune complexes (CICs) are implicated in various diseases, including cancer.

Purpose of the Study:

• To quantify serial CIC levels in colorectal cancer patients before and after surgery.
• To correlate CIC levels with carcinoembryonic antigen (CEA) values and tumor course.
• To investigate the role of CICs in the host immune response to colorectal cancer.

Main Methods:

• An antigen-nonspecific assay using 4% polyethylene glycol insolubilization was employed to measure CIC levels.
• Serial serum samples were collected from patients with primary or metastatic colorectal cancer.
• CIC levels were compared to carcinoembryonic antigen (CEA) values and clinical tumor status.

Main Results:

• All colorectal cancer patients presented with elevated CIC levels compared to healthy controls (p < 0.05).
• Progressive CIC increases correlated with tumor removal or significant response to regional therapy, indicated by declining CEA.
• Unexpectedly high IgA concentrations were found in serum samples from patients with gastrointestinal cancers during presumed antibody excess.

Conclusions:

• Serial CIC quantitation provides insights into the kinetics of immune complex changes during tumor progression and treatment.
• The study suggests a dynamic host immune response reflected by CIC levels in colorectal cancer.
• Findings confirm previous observations in gestational tumors and offer a novel perspective on immune complexes in cancer growth.